Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study

BACKGROUND/AIMS: The efficacy and safety of vedolizumab in moderate to severely active ulcerative colitis (UC) have been demonstrated in the GEMINI 1 study (NCT00783718). This post-hoc exploratory analysis sought to establish the efficacy and safety of vedolizumab in a subgroup of patients from Asia...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Intest Res
Huvudupphovsmän: Ooi, Choon Jin, Hilmi, Ida Normiha, Kim, Hyo-Jong, Jalihal, Umesh, Wu, Deng-Chyang, Demuth, Dirk, Lindner, Dirk, Adsul, Shashi
Materialtyp: Artigo
Språk:Inglês
Publicerad: Korean Association for the Study of Intestinal Diseases 2021
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7873399/
https://ncbi.nlm.nih.gov/pubmed/32877600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5217/ir.2019.09159
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk